Rapid City Workplace Accessibility Grant

The Affordable Commercial Tenanting (ACT) Grant provides Portland property owners and small business owners with reimbursement grants of up to $300,000 to fund tenant improvements, space related soft costs, and permitting support needed to ready a commercial space for opening. Administered by Prosper Portland, the city's economic development agency, the program is designed to facilitate access to affordable commercial space and support inclusive small business growth by helping local entrepreneurs move into ground floor storefronts at a lower cost. The grant is currently available for properties located within the Interstate Corridor and Gateway Regional Center Tax Increment Finance (TIF) Districts, though the program may expand to other areas of the city in the future. To qualify, the property owner must agree to provide the small business with a minimum three year lease that includes at least one of the following: a lease rate 10 to 25 percent below market, a period of rent abatement, or capped rent escalations during the affordable rate period. The property must be ground floor and zoned for commercial or mixed use. Eligible business owners must demonstrate at least two years of business experience and meet criteria related to displacement, limited access to capital, first generation business ownership, or location within a low income census tract. Funds may be used for hard costs to ready the space (such as standard finishes, signage, landscaping, lighting, and security upgrades), up to $25,000 for soft costs like design and permitting fees, and up to $25,000 for predevelopment work. Operating expenses, inventory, and non permanent fixtures are not eligible. Property management companies, mobile businesses, e-commerce businesses, and cannabis businesses are not eligible to apply.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic research to understand disease, or in applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease. The rationale is to deliver new capabilities to meet evolving requirements for technologies and methods relevant to the advance of research and delivery of care in pre-clinical, clinical and non-clinical settings, domestic or foreign, for conditions and diseases within the missions of participating institutes.

Each year, we select 50 women entrepreneurs for a yearlong program designed to grow their businesses through workshops, coaching sessions, network-building, and financial resources. The program ends with a company presentation and in-person experience. In addition to educational resources and networking opportunities, the fellowship awards a $5,000 grant to each participant and access to 0%-interest Kiva loans.

The Job Development Investment Grant (JDIG) is a performance-based, discretionary incentive program that provides cash grants directly to a company, when the company creates jobs and invests in the state. Grants are awarded only in competitive recruitment or retention situations. JDIG grants hold companies to strict performance targets, but the grants can significantly help offset the cost of locating or expanding a facility in the state. JDIG grant payments are determined using a formula that takes into consideration the new taxes generated by the new jobs that are created. A percentage of those newly generated funds are reimbursed to the awarded company, for the limited term of the grant and as long as the company meets its performance target.

The Rhode Island Lift Program is a strategic investment initiative designed to fuel the growth and successful capital raise of high-impact life sciences companies in Rhode Island. This competitive program provides a non-dilutive funding boost to companies that have finalized or recently closed a funding round. By offering this last infusion of capital, the program helps high-potential life sciences ventures scale their operations, drive innovation, and strengthen their impact on the state’s economy, industry growth, and patient outcomes. Through this support, Rhode Island continues to position itself as a leader in life sciences advancement and commercialization.